Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702509 | Urologic Oncology: Seminars and Original Investigations | 2017 | 7 Pages |
Abstract
Compared to traditional PN, TE is an effective and safe treatment for T1 renal tumors, and TE appears to have acceptable early oncology outcomes. Owing to the limited number of clinical trials and the predominantly retrospective data on this subject, there is a need for properly designed studies to confirm our findings.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
De-Hong M.D., Liang-Ren M.D., Yu M.D., Ping M.D., Tao M.D., YunJin M.D., Jia M.D., Qiang M.D.,